MVM Life Science Partners LLP
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Growth
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Luxembourg, Ireland, Austria, Netherlands, Hungary, Portugal, Belgium, Norway, Finland, Poland, Czech Republic, Romania
Industries Focus
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Vaccines
- Medical Technology
- Healthcare IT
- Biopharmaceuticals
- Health IT
- Life Science Tools
- Gene Therapy
- Contract Manufacturing
- Drug Delivery
- Contract Research
- OTC Medicines
Investment Size:
20,000,000 to 100,000,000 USD
Investor Details Founded: 1997
MVM Life Science Partners LLP is a venture capital firm specializing in early-stage investments in life sciences and healthcare companies. Founded in 1997, the firm has a global presence with offices in London and Boston, managing funds totaling over US$700 million. MVM focuses on sectors such as biopharmaceuticals, medical devices, diagnostics, digital health, and gene therapy, aiming to support innovative companies addressing significant unmet medical needs.
The firm's investment strategy involves providing equity to high-growth companies with differentiated technologies. MVM collaborates closely with management teams to accelerate growth, drive strategic acquisitions, and establish new standards of care in medicine. The firm has a track record of successful exits, including both acquisitions and initial public offerings, demonstrating its commitment to building world-class companies in the healthcare sector.
MVM's portfolio includes a range of companies across the life sciences market, reflecting its broad investment remit. The firm seeks out businesses with innovative products that have the potential to transform healthcare delivery and improve patient outcomes. By leveraging its deep sector expertise and strategic support, MVM aims to help portfolio companies achieve their full potential and make a significant impact on the healthcare industry.
Requirements
- Innovative products addressing significant unmet medical needs
- Differentiated technologies with durable protection against competition
- Strong management teams with a clear vision for growth
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Avanzanite
- GT Medical Technologies
- Nalu Medical
- ProVerum
- Paratek Pharmaceuticals
- Zimmer Biomet
- icotec
- Hologic
- OSSIO
Mentioned In
-
$24.95
-
$19.95
-
$24.95
-
$19.95
-
$49.95
-
$19.95
-
$39.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of MVM Life Science Partners LLP?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim